Atricure Inc. buy Needham & Company LLC
Start price
29.11.23
/
50%
€27.40
Target price
29.11.24
€44.64
Performance (%)
-
End price
30.11.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | - | - | - |
| iShares Core DAX® | 1.432% | 1.580% | 13.249% |
| iShares Nasdaq 100 | 1.892% | -2.280% | 2.995% |
| iShares Nikkei 225® | -1.619% | 7.954% | 27.694% |
| iShares S&P 500 | 1.921% | -0.277% | 2.994% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $49.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten